Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Remegen
company
About
Remegen is a biotech company focused on discovering and developing a new generation of targeted therapies for the treatments of cancer.
- 11 - 50
Details
- Last Funding Type
- Private Equity（PE）
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
RemeGen, Ltd. ("RemeGen") is a biopharmaceutical company in China dedicated to fulfilling unmet medical needs for patients with life-threatening conditions. RemeGen's main focus is research and development, manufacturing and commercialization of novel biologics, most notably monoclonal antibodies (mAb) and antibody-drug conjugates (ADCs). Headquartered in Yantai, Shandong Province, China, RemeGen has labs/offices in Beijing and California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$100M
Remegen has raised a total of
$100M
in funding over 2 rounds. Their latest funding was raised on
Mar 17, 2020 from a Private Equity（PE） round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 17, 2020 | Private Equity（PE） | $100M | 1 |
Lilly Asia Ventures
|
— | Detail |
| Dec 7, 2019 | Private Equity（PE） | — | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Remegen is funded by 3 investors.
Lilly Asia Ventures
and Huatai Health Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lilly Asia Ventures
|
Yes | Private Equity（PE） |
|
|
— | Private Equity（PE） |
Mingxin China Growth Fund
|
— | Private Equity（PE） |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
